• Human B7-H5/Gi24/VISTA protein (Recombinant) (C-His) (STJP001028)

Human B7-H5/Gi24/VISTA protein (Recombinant) (C-His) (STJP001028)

SKU:
STJP001028

Current Stock:
Host: HEK293 cells
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Recombinant-Human B7-H5/Gi24/VISTA-C-His protein was developed from hek293 cells and has a target region of C-His. For use in research applications.
Formulation: Lyophilized from a 0.22 Mu m filtered solution of PBS, pH 7.4. Contact us for customized product form or formulation.
Gene Symbol: VSIR
Gene ID: 64115
Uniprot ID: VISTA_HUMAN
Immunogen: Recombinant Human B7-H5/Gi24/VISTA Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Phe 33-Ala 194 ) of human VISTA/B7-H5/PD-1H (Accession #AAH20568.1) fused with a 6×His tag at the C-terminus.
Post Translational Modifications At the cell surface, may be cleaved by MMP14. N-glycosylated.
Function Immunoregulatory receptor which inhibits the T-cell response. May promote differentiation of embryonic stem cells, by inhibiting BMP4 signaling. May stimulate MMP14-mediated MMP2 activation.
Protein Name V-Type Immunoglobulin Domain-Containing Suppressor Of T-Cell Activation
Platelet Receptor Gi24
Stress-Induced Secreted Protein-1
Sisp-1
V-Set Domain-Containing Immunoregulatory Receptor
V-Set Immunoregulatory Receptor
Cellular Localisation Cell Membrane
Single-Pass Type I Membrane Protein
Alternative Protein Names V-Type Immunoglobulin Domain-Containing Suppressor Of T-Cell Activation protein
Platelet Receptor Gi24 protein
Stress-Induced Secreted Protein-1 protein
Sisp-1 protein
V-Set Domain-Containing Immunoregulatory Receptor protein
V-Set Immunoregulatory Receptor protein
VSIR protein
C10orf54 protein
SISP1 protein
VISTA protein
PP2135 protein
UNQ730 protein
PRO1412 protein

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance